Deal Announcement: Seneca Property

CHRYSTAL CAPITAL INTRODUCES FAMILY OFFICES AND UHNWI CO-INVESTORS TO SENECA PROPERTY

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has acted as an introducer of capital to Seneca Property Investments Limited (“Seneca Property), an independent real estate investor, on its c.£6m purchase of the Tempus Court, Guildford, at a c.12.5% yield.  

The freehold property is characterised by a recent high grade communal area refurbishment, town centre location, 37 car parking spaces, 7 quality tenants providing a diverse income profile; and has room for asset management.  As with all our transactions alongside Seneca Property we have a significant initial cash yield on equity (10%) and a target net IRR in excess of 20% on a 3 year investment horizon.   

“Our investors like to work with experienced co-investment partners who have been in the market a long time. They know who the sellers are of premium assets in excellent locations. This is now our third deal with Seneca in little over a year and we hope to deploy more capital with them in 2025”

— James Innes, Managing Partner, Chrystal Capital

“There is a significant disconnect between market perception of commercial property risk in the regions and the realities. We are experienced operators of sub £10m sites and look to structure deals with low leverage and high equity returns.”

— Chris Bullough, Managing Director, Seneca Property

About Seneca Property 

Seneca Property is an independent real estate investor which seeks to provide exceptional income and growth investment opportunities for investors. Seneca invest across a range of sectors including office, retail, leisure, industrial, residential and healthcare. 

For more information about Seneca Property, please visit https://senecaproperty.com/.  

About Chrystal Capital Co-investments 

Single Family Offices (SFOs) and Ultra High Net Worth Individuals (UHNWIs) are continually seeking access to high quality, professionally structured and well managed co-investment opportunities across a range of asset classes, without having to directly source and negotiate these opportunities. The ideal scenario enables our clients to cherry pick the investment opportunities they participate in, with limited demands on their time and resources. 

Through our relationships with institutional investors, we enable SFOs and UHNWIs to gain access to attractive investment opportunities that they might otherwise not be aware of. We provide curated deal flow across a variety of sectors, asset classes and structures – all tailored to known, specified preferences. 

For more information about Chrystal Capital please visit https://www.chrystalcapital.com. 

 
For further information please contact:  
James Innes, Managing Partner 
james.innes@chrystalcapital.com  
https://www.chrystalcapital.com  

Deal Announcement: Seneca Property

CHRYSTAL CAPITAL INTRODUCES FAMILY OFFICES AND UHNWI CO-INVESTORS TO SENECA PROPERTY 

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has acted as an introducer of capital to Seneca Property Investments Limited (“Seneca Property), an independent real estate investor, on its £6m purchase of the The Place, Maidenhead.   

The freehold property is characterised by its high EPC rating, town centre location, quality tenants with room for asset management.  As with all our transactions alongside Seneca Property we have a significant initial cash yield on equity and a target net IRR in excess of 20% on a 3 year investment horizon.    

“Interest rates are coming down. There are motivated sellers of quality commercial assets in the regions. We have downside protection through low leverage and a high quality building and tenants. If you want to get income of c.10% and are not constrained by timing then we believe that such investments should be a great addition to a wider investment portfolio.”

— James Innes, Managing Partner, Chrystal Capital

“It was very nice to see that the investors from the Chrystal network chose to back us into another property transaction. For those who know that life exists outside of London and are willing to make investment returns by being contrarian to the institutional investment houses then we would welcome a chat as there are plenty more opportunities to take advantage of.”

— Chris Bullough, Managing Director, Seneca Property

About Seneca Property 

Seneca Property is an independent real estate investor which seeks to provide exceptional income and growth investment opportunities for investors. Seneca invest across a range of sectors including office, retail, leisure, industrial, residential and healthcare. 

For more information about Seneca Property, please visit https://senecaproperty.com/.  

About Chrystal Capital Co-investments 

Single Family Offices (SFOs) and Ultra High Net Worth Individuals (UHNWIs) are continually seeking access to high quality, professionally structured and well managed co-investment opportunities across a range of asset classes, without having to directly source and negotiate these opportunities. The ideal scenario enables our clients to cherry pick the investment opportunities they participate in, with limited demands on their time and resources. 

Through our relationships with institutional investors, we enable SFOs and UHNWIs to gain access to attractive investment opportunities that they might otherwise not be aware of. We provide curated deal flow across a variety of sectors, asset classes and structures – all tailored to known, specified preferences. 

For more information about Chrystal Capital please visit https://www.chrystalcapital.com. 

 
For further information please contact:  
James Innes, Managing Partner 
james.innes@chrystalcapital.com  
https://www.chrystalcapital.com  

Deal Announcement: SmartRecruiters

CHRYSTAL CAPITAL INTRODUCES CO-INVESTORS TO SECONDARY CAPITAL

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has acted as introducer of capital to Secondary Capital on its acquisition of secondary shares in SmartRecruiters (“SmartRecruiters”), a hiring platform that covers the full spectrum of recruitment, from career sites to applicant tracking and onboarding.

“It was a pleasure to work with Secondary Capital once again. Their expertise and collaborative approach make them an outstanding co-investment partner. We look forward to continuing our successful partnership in the future.”

— James Innes, Managing Partner, Chrystal Capital

“We’re thrilled to have partnered again on this investment. The collaboration was seamless, and we value the strong relationships we’ve built with Chrystal Capital and their extensive network of Family Offices. We are excited about the future and look forward to more opportunities to work together.”

— Cedric Abitbol, Secondary Capital

About SmartRecruiters (“SmartRecruiters”)

SmartRecruiters enables hiring without boundaries by freeing talent acquisition teams from legacy applicant tracking software. SmartRecruiters' next-generation platform serves as the hiring operating system for 4,000 customers like Bosch, LinkedIn, Skechers, and Visa. Companies with business-critical hiring needs turn to SmartRecruiters for best-of-breed functionality, world-class support, and a robust ecosystem of third-party applications and service providers.

For more information about SmartRecruiters, please visit https://www.smartrecruiters.com/.

About Chrystal Capital Co-investments

Single Family Offices (SFOs) and Ultra High Net Worth Individuals (UHNWIs) are continually seeking access to high quality, professionally structured and well managed co-investment opportunities across a range of asset classes, without having to directly source and negotiate these opportunities. The ideal scenario enables our clients to cherry pick the investment opportunities they participate in, with limited demands on their time and resources.

Through our relationships with institutional investors, we enable SFOs and UHNWIs to gain access to attractive investment opportunities that they might otherwise not be aware of. We provide curated deal flow across a variety of sectors, asset classes and structures – all tailored to known, specified preferences.

For more information about Chrystal Capital please visit https://www.chrystalcapital.com.

About Secondary Capital (“SC”)

SC was established by veteran Private Markets Investors, active in both primary and secondary transactions since the early 2000's.

SC is aligned to a fundamental shift that companies are staying private longer and need transitional capital to provide liquidity to early investors, founders and executives.  SC, as a direct secondary specialist, provides liquidity to shareholders (founders, executives, VC funds and other early investors) of late-stage and growth companies.

For more information about Secondary Capital please visit https://www.secondary-capital.com.

For further information please contact: 
James Innes, Managing Partner
james.innes@chrystalcapital.com 
https://www.chrystalcapital.com 

Deal Announcement: Alto Pharmacy

CHRYSTAL CAPITAL INTRODUCES CO-INVESTORS TO SECONDARY CAPITAL  

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has acted as introducer of capital to Secondary Capital on its acquisition of secondary shares in Alto Pharmacy (“Alto”), a US leading digital pharmacy.   

“Secondary share purchases in well-established, profitable and well-funded tech businesses; through founder led processes, is an area that we had been trying to gain access to for some time. Having now completed our first transaction with Secondary Capital in Alto Pharmacy we look forward to working with them with regards to their investments in other US and European based opportunities.”

— James Innes, Managing Partner, Chrystal Capital

“Chrystal Capital introduced us to a significant number of family offices and private individuals based in both the UK and Europe. They worked alongside us to present the investment case in Alto Pharmacy and it was clear that they have the trust of their network.”

— Cedric Abitbol, Secondary Capital

About Alto Pharmacy (“Alto”) 

Alto is America's leading digital pharmacy with free hand-delivery, easy-to-reach pharmacists, and automatic savings investigations. Founded in 2015, Alto’s better pharmacy model is centered on the critical role of pharmacists as the final link in a person’s health journey and combines expert pharmacist care with purpose-built technology to deliver a more convenient and affordable experience for those who need medication. To date, Alto has fulfilled more than three million prescriptions, expanded to twelve markets, and built a mobile app experience that makes it easier than ever to manage medications and chat with a pharmacist.  

For more information about Alto Pharmacy, please visit https://alto.com/. 

About Chrystal Capital Co-investments 

Single Family Offices (SFOs) and Ultra High Net Worth Individuals (UHNWIs) are continually seeking access to high quality, professionally structured and well managed co-investment opportunities across a range of asset classes, without having to directly source and negotiate these opportunities. The ideal scenario enables our clients to cherry pick the investment opportunities they participate in, with limited demands on their time and resources. 

Through our relationships with institutional investors, we enable SFOs and UHNWIs to gain access to attractive investment opportunities that they might otherwise not be aware of. We provide curated deal flow across a variety of sectors, asset classes and structures – all tailored to known, specified preferences. 

For more information about Chrystal Capital please visit https://www.chrystalcapital.com. 

About Secondary Capital (“SC”) 

SC was established by veteran Private Markets Investors, active in both primary and secondary transactions since the early 2000's. 

SC is aligned to a fundamental shift that companies are staying private longer and need transitional capital to provide liquidity to early investors, founders and executives.  SC, as a direct secondary specialist, provides liquidity to shareholders (founders, executives, VC funds and other early investors) of late-stage and growth companies. 

For more information about Secondary Capital please visit https://www.secondary-capital.com. 

 
For further information please contact:  
James Innes, Managing Partner 
james.innes@chrystalcapital.com  
https://www.chrystalcapital.com  

Deal Announcement: Seneca Property

CHRYSTAL CAPITAL INTRODUCES FAMILY OFFICES AND UHNWI CO-INVESTORS TO SENECA PROPERTY

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has acted as an introducer of capital to Seneca Property Investments Limited (“Seneca Property), an independent real estate investor, on its £7m purchase of the Premier Inn, Preston.  

“We work closely with several family offices to develop new investment theses and there is demand for the protection and income that real assets provide. We therefore went into the market and spent time speaking with property asset managers and decided to work with Seneca as their approach of buying quality assets at discounted prices from motivated sellers resonated with both us and our network.”

— James Innes, Managing Partner, Chrystal Capital

“

There is no doubt that Chrystal Capital have demonstrated the broad network of investors that trust their judgement on picking investment partners. The process has been both professional in nature and been completed in a timely manner.
”

— Chris Bullough, Managing Director, Seneca Property

About Seneca Property

Seneca Property is an independent real estate investor which seeks to provide exceptional income and growth investment opportunities for investors. Seneca invest across a range of sectors including office, retail, leisure, industrial, residential and healthcare.

For more information about Seneca Property, please visit https://senecaproperty.com/.

About Chrystal Capital Co-investments

Single Family Offices (SFOs) and Ultra High Net Worth Individuals (UHNWIs) are continually seeking access to high quality, professionally structured and well managed co-investment opportunities across a range of asset classes, without having to directly source and negotiate these opportunities. The ideal scenario enables our clients to cherry pick the investment opportunities they participate in, with limited demands on their time and resources.

Through our relationships with institutional investors, we enable SFOs and UHNWIs to gain access to attractive investment opportunities that they might otherwise not be aware of. We provide curated deal flow across a variety of sectors, asset classes and structures – all tailored to known, specified preferences.

For more information about Chrystal Capital please visit https://www.chrystalcapital.com.

For further information please contact: 
James Innes, Managing Partner
james.innes@chrystalcapital.com 
https://www.chrystalcapital.com 

Deal Announcement: Velocity Black

 Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that Velocity Black (“Velocity”), a leading digital concierge company that delivers travel, entertainment, shopping and dining offerings to consumers globally, has been sold for a reported USD296m to Capital One (NASDAQ: COF; $42.5bn market cap) .

Chrystal was one of the early investors and subsequently raised over £22m for Velocity across its Post-Seed, Series A and Series B rounds. The raises were supported by a combination of High Net Worth's and family offices from our global network. Importantly the company also attained Enterprise Investment Scheme authorisation meaning investors that too EIS were able to capture all their capital gains tax free.

“We are delighted to have supported Velocity with its critical growth capital during the early years of its technology development.  Alex and Zia have been pioneers in using AI to disrupt a large addressable market and the success of their vision has clearly been borne out in the value Capital One have ascribed to the business.  The 100% sale of Velocity to Capital One marks the end of a highly successful journey for our investors who backed Velocity through multiple rounds at valuations significantly below the ultimate acquisition price.”

— Kingsley Wilson, Investment Partner

About Velocity Black

Founded in 2014 on the principle that time is our most precious asset, Velocity deploys cutting edge technologies and human experts to transform how high performance people discover and enjoy their world.  They help their  members do and be more in the digital age.

Velocity has built a unique customer experience — its proprietary platform deploys cutting edge technology and human experts to offer inspiration, recommendation and fulfilment in one place, making it an integral part of customers’ lives.  It harnesses the power of artificial intelligence,  the warmth of human experts and the convenience of the latest interfaces to help high performance people actualise the full potential of their lives.  They curate the best life has to offer, then their engine puts it at their members’ fingertips. Welcome to the conversational interface.

To learn more about Velocity Black, visit https://velocity.black/. 

About Chrystal Capital Digital Economy 

We work with companies that are using technology combined with a scalable business model, to significantly influence an existing market.

We believe that Digital Marketplaces and eCommerce businesses are attractive to investors due to the speed and scale to which they can grow by offering a clear customer proposition, with transparent pricing and ease of delivery. They are more capital efficient than traditional companies and can quickly command a dominant market position that is difficult to usurp.

Digital Marketplaces and eCommerce propositions have been a high priority for any tech savvy investor over the past decade – with those who have invested benefiting from the positive market forces that have surrounded the shifts in behaviour of the buyers and sellers of products and services.

Whether operating in a large established market or a niche it has been repeatedly seen that one company can dominate the landscape in a very short period of time. Due to the virtuous circle that is created between the buyers and sellers these companies with ever increasing brand presence can be difficult to dislodge.

For more information about Chrystal Capital please visit https://www.chrystalcapital.com.

For further information please contact: 
James Innes, Managing Partner
james.innes@chrystalcapital.com 
https://www.chrystalcapital.com 

Deal Announcement: Northern Leaf

CHRYSTAL CAPITAL INTRODUCES FAMILY OFFICES AND UHNWI INVESTORS INTO NORTHERN LEAF

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair based corporate finance and investment house, is pleased to announce that it has acted as exclusive financial advisor to Northern Leaf Limited (“Northern Leaf”), a Jersey based medical cannabis cultivator, on its £3m Pre-IPO preference share fundraise. 

Chrystal has been involved with the management team at Northern Leaf since its inception in 2019, acting as the exclusive advisor on its £1.9m founders round in 2020, and on the subsequent £14.25m Convertible Loan Note raise in March 2021. Since then, the company has achieved a number of critical milestones: 

• Awarded the second ever commercial high THC licence behind GW Pharma 22 years prior. 

• Built out a state of the art 75,000 sq. ft cannabis cultivation, drying and processing facility capable of delivering 9 tonnes of cannabis flower per annum. 

• Secured multiple exclusive high THC genetics strains which have now been grown across numerous batch cycles proving quality and consistency of flower for the European medical cannabis markets. 

• Passed final facility inspections by the MHRA, positioning Northern Leaf to be awarded EU GMP accreditation, expected imminently, which will enable sales across Europe and other medically legal jurisdictions globally.  

• Employed a number of highly experienced industry personnel across the critical areas of cultivation, operations, sales, quality control and regulation. 

• Appointed market leading advisors across accounting, legal and broking in anticipation of a summer 2023 IPO onto the London Stock Exchange. 

“We are delighted to have supported and advised Northern Leaf again on its third financing. Since inception the strategy has always been to build a European leading medical cannabis business to provide critical and much needed medical products to millions of patients across Europe and further afield suffering from a wide variety of ailments. This additional capital raise will allow Northern Leaf to continue on that path to becoming one of the most strategically important assets in Europe whilst providing much needed medical solutions to patients currently lacking high quality EU GMP supply.”

— Kingsley Wilson, Investment Partner, Chrystal Capital

“Chrystal Capital has been a strong supporter and advisor to Northern Leaf, since its inception in 2019, being integral to our growth and market positioning success. We are excited, after years of capital investment, regulatory clearances, and building the right management team, to begin the monetisation phase of this world class European medical cannabis asset.”

— Don Perrott, CEO, Northern Leaf

About Northern Leaf 

Northern Leaf is a medical cannabis cultivator based in Jersey that, in December 2020, was granted the first UK commercial high THC medical cannabis license since UK based GW Pharmaceuticals (NASDAQ:GWPH) in 1998. The Company is leading the development of a new industry for the British Isles, creating centres of excellence, using state-of-the-art tracking systems and robust policies and procedures to ensure the highest levels of quality from seed to sale. With a secure, operational facility already built, Northern Leaf will grow commercial quantities of medical cannabis for the rapidly growing European market, including the key markets of the UK, Germany, and Israel.  

For more information about Northern Leaf, please visit https://www.northern-leaf.com/. 

About Chrystal Capital Health and Wellness 

Within Chrystal Capital Health & Wellness division, we have one of the leading Cannabis Corporate Finance advisory teams in Europe. They have closed 19 cannabis deals in the last six years, raising and advising on over US$475m of transactions in the pharmaceutical, medical, wellness and cannabis sub-sectors across Europe, North America, and Latin America. They are actively advising clients on IPOs, dual-lists, private capital raises and M&A. 

For more information about Chrystal Capital please visit https://www.chrystalcapital.com.

For further information please contact: 
Kingsley Wilson

Investment Partner
kingsley.wilson@chrystalcapital.com 
https://www.chrystalcapital.com 

Deal Announcement: Cera Care

CHRYSTAL CAPITAL INTRODUCES FAMILY OFFICES AND UHNWI CO-INVESTORS INTO CERA CARE ALONGSIDE GUINNESS VENTURES

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has brought co-investors from its family office and UHNWI network into Cera Care (“Cera”); a digital-first healthcare-at-home service delivering care, nursing, telehealth and repeat prescription services in people’s homes, via technology.

The funds, invested via a UK nominee structure, will be managed by Guinness Ventures (“Guinness”), an existing investor in Cera Care having invested via the Guinness EIS fund. Other notable investors in this round include; Credo Ventures, Kairos, Jane Street Capital and Schroders Capital.

“We believe that there is significant value to be had for our network to invest in businesses of scale, alongside institutional capital. There is a gap in the market where existing investors, for a variety of reasons, cannot participate in follow-on rounds. We have a focused list of current opportunities and would welcome conversations with those that find the idea of a low cost entry point, into top tier opportunities, alongside ‘Blue Chip’ operators, appealing.”

— James Innes, Managing Partner, Chrystal

“We are pleased to announce that we have now closed this round of financing. Thanks to the help of Chrystal we can continue to support Cera Care in bringing their vision of in-home care to life. Chrystal were instrumental in taking much of the strain of the marketing and deal transaction processes.”

— Shane Gallwey, Head of Ventures, Guinness Ventures

About Cera

Cera, founded in 2015, provides elderly and vulnerable communities with care in their own homes, and allows families to arrange the care. As one of Europe’s fastest-growing companies, they are redefining healthcare by moving more and more services out of hospitals and into people’s own homes. Their smart, digital technology leverages data and machine learning to empower those providing care, whilst improving outcomes for those receiving it.

For those delivering care, Cera reduces the burden of ‘pen and paper’ working and remove unnecessary administrative work, empowering them to do what they do best: care.

For those receiving care at home Cera are able to monitor their condition digitally, predicting and preventing changes in their condition and responding to any deterioration 30-fold faster than traditional methods, reducing hospitalisations, and keeping people well in their homes.

For more information, see https://ceracare.co.uk/

About Guinness

Guinness has invested into growth businesses since 2010, providing capital to a wide range of UK companies backing outstanding entrepreneurs and businesses with disruptive and ambitious growth plans. They have successfully supported the growth of over 100 companies since 2010 and are always excited to meet passionate entrepreneurs.

For more information, see https://www.guinnessgi.com/

About Chrystal

Chrystal is an entrepreneurial corporate finance and investment house with an established global network of Single Family Offices, Ultra High Net Worth Individuals and private equity co-investment partners. We act as a conduit between our network members, providing bespoke solutions for their capital and investment objectives.

Our core sectors are Digital Economy, Health & Wellness, Sustainable & Impact Investments, and Natural Resources.

Our service areas are Advisory, Principal Investments and Co-investments.

For further information please contact:

James Innes
Managing Partner
james.innes@chrystalcapital.com
https://www.chrystalcapital.com

Deal Announcement: Iofina Plc

CHRYSTAL CAPITAL APPOINTED AS FINANCIAL ADVISOR TO IOFINA Plc.

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has advised Iofina Plc.

“Iofina is a company that we know well and have followed since it first listed back in 2018.  The underlying product has a seen a resurgence in value as the multitude of uses for iodine have come to the fore in an ever-increasing unstable World.  We look forward to introducing the story to not only London based institutions but also a wide plethora of family offices from natural resources, industrials, and medical backgrounds.”

— James Innes, Managing Partner, Chrystal Capital

“We have known the Chrystal team for a significant number of years and they have been active supporters and investors.  As Iofina enters the next phase of its growth story it is keen to re-engage with those institutional investors that may have once been keen on the story but also new sources of long-term capital who can support us through both acquisitions and organic growth”

— Lance Baller, CEO, Iofina

About Iofina

Iofina plc is a vertically integrated Company that specializes in the exploration and production of iodine and the manufacturing of specialty chemical derivatives. Through its commitment to technology development and investing in its people, Iofina successfully services markets around the globe via its business lines, Iofina Resources and Iofina Chemical.

Iofina Resources (“IR”) is the Group’s iodine production business which isolates iodine using the Group’s proprietary WET® IOsorb® technologies.  Unlike other major US manufacturers, Iofina isolates iodine that is recovered from the brine produced from oil and gas operations that would otherwise be wasted.  IR has become the second largest producer of iodine in North America, which currently imports a vast majority of its iodine.  Iodine has numerous applications in human health, biocides, acetic acid manufacturing and many others.  IR’s crystalline IOflo® iodine is either sold directly to global customers or converted to iodine based compounds at its sister company Iofina Chemical.

Established in 1983 and acquired by Iofina in 2009, Iofina Chemical (“IC”) is the Group’s technology focused, halogen-based specialty chemical producer. IC has and continues to invest heavily in researching and developing new iodo-, chloro-, and fluoro-based specialty compounds and provides the global market with quality iodine products, supported with strong, technical customer support.

For more information, see https://iofina.com/

About Chrystal Capital

Chrystal Capital is a corporate finance and investment house with an established global network of Single Family Offices, Ultra High Net Worth Individuals and private equity co-investment partners. We act as a conduit between our network members, providing bespoke solutions for their capital and investment objectives.

Our core sectors are Digital Economy, Health & Wellness, Sustainable & Impact Investments, and Natural Resources.

Our service areas are Advisory, Principal Investments and Co-investments.

For further information please contact:

Rak Karia
Director, Head of Natural Resources
raj.karia@chrystalcapital.com
https://www.chrystalcapital.com

Deal Announcement: carwow

CHRYSTAL CAPITAL ACTS AS FINANCIAL ADVISOR TO CARWOW

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has advised Carwow to bring in GLy New Mobility Fund, a prominent international investment group, as part of a larger raise alongside leading UK private equity groups Balderton, Accel and Vitruvian.

“Carwow is disrupting the European consumer car market through its innovative offering and technology stack. To complete a fund raise in challenging markets is a testament to the strength of their high growth, high margin business that is both proven and scalable.”

— James Innes, Managing Partner, Chrystal

“Whatever it is, the way you tell your story online can make all the difference.“The Chrystal team worked relentlessly to introduce a broad range of strategic investors. Their reach was international and through their background in digital marketplaces they were able to communicate a clear investment case.””

— James Hind, CEO, carwow

About Carwow

UK-based Carwow is the largest online marketplace for brand new cars in Europe and is backed by several leading institutional venture capital firms including Balderton, Accel and Vitruvian Partners, as well as Mercedes-Benz’s parent company Daimler AG.

The carwow platform helps consumers learn about the available vehicles in the market, connecting them directly to dealers who provide offers for their chosen vehicle type. This helps consumers to get the best visibility on the markets, comparing prices, financing, delivery times and dealer quality. Whilst on the other side of the marketplace, dealers are able to capture demand from across the country with qualified leads. carwow also makes a significant and growing portion of its revenues from alternative sources, including their ‘Sell Your Car’ product, bolstered by the acquisition in June 2021 of Wizzle, as well as from original equipment manufacturers (OEMs) advertising on their platform, and from their YouTube channel.

For more information, see https://www.carwow.co.uk/

About Chrystal Capital

Chrystal Capital is a corporate finance and investment house with an established global network of Single Family Offices, Ultra High Net Worth Individuals and private equity co-investment partners. We act as a conduit between our network members, providing bespoke solutions for their capital and investment objectives.

Our core sectors are Digital Economy, Health & Wellness, Sustainable & Impact Investments, and Natural Resources.

Our service areas are Advisory, Principal Investments and Co-investments.

For further information please contact:

James Innes Managing Partner

james.innes@chrystalcapital.com

https://www.chrystalcapital.com

Deal Announcement: Remilk

CHRYSTAL CAPITAL INTRODUCES FO AND UHNWI CO-INVESTORS INTO A SECONDARY PLACING OF REMILK, ALONGSIDE RAGE CAPITAL

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has brought members of its family office and UHNWI network into Remilk, a leading precision fermentation company crafting real dairy without a single cow. The investment will be managed by Rage Capital.

“Our co-investment and secondary platform is based on the ability to source and work closely with top tier GPs globally.  This is demonstrated by this latest transaction with Rage Capital who have a demonstrable track record in the alternative proteins space.  I would encourage investors who are open to the idea of having a strong GP alongside them and who want global access to deal flow to come forward to speak to the Chrystal Capital team.”

— James Innes, Managing Partner, Chrystal rce

About Remilk

Remilk is a precision fermentation company that modifies yeast microorganisms to synthesize the proteins found in cow's milk, primarily whey and casein - unlocking the $800B+ dairy market. Precision fermentation is the process of genetically engineering microorganisms (in this case, yeast strains) to stimulate them to produce pure molecules, as has been done in pharma for decades.

Dairy crafted Remilk’s way is a breath of fresh air, with its production process emitting up to 97% less greenhouse gases! It also requires an estimate of around 1% of the land, 4% of the feedstock and less than 10% of the water compared to traditional dairy production - with zero animals harmed.

Remilk has achieved best-in-class yeast titers (or yield) within less than 3 years, a tremendous feat that is further corroborated by customers' positive reviews of the company's proteins.

For more information, see www.remilk.com.

About Chrystal Capital

Chrystal Capital is a corporate finance and investment house with an established global network of Single Family Offices, Ultra High Net Worth Individuals and private equity co-investment partners. We act as a conduit between our network members, providing bespoke solutions for their capital and investment objectives.

For more information, see www.chrystalcapital.com.

About Rage Capital

Rage Capital is a specialist venture capital firm based in New York, investing in cutting edge technology to change the way we eat, live and interact with our planet. Other investments in its portfolio include Blue Nalu, Motif, Ripple, Reef, Future Farm and Splendid Spoon.

For more information, see www.rage-capital.com.

For further information please contact:

James Innes Managing Partner

james.innes@chrystalcapital.com

https://www.chrystalcapital.com

Deal Announcement: Change Agronomy

Chrystal Capital acts as exclusive advisor to Change Agronomy on £9.6m fundraise

Chrystal Capital Partners LLP (“Chrystal Capital”), is an entrepreneurial corporate finance and investment house with an established global network of Single Family Offices (SFOs), Ultra High Net Worth Individuals (UHNWIs) and private equity co-investment partners. Chrystal Capital’s core sector focus are, Health & Wellness, Sustainable & Impact Investments and Digital Economy. Chrystal Capital is pleased to announce that it has acted as exclusive financial advisor to Change Agronomy Limited (“Change Agronomy” or “the Company”), an integrated sustainable industrial hemp company, on its £9.6m capital raise via an issue of £7.0m of equity and £2.6m of debt.  

Change Agronomy will use the capital to roll out its whole plant usage industrial hemp hubs geographically to provide multiple blue chip companies with consistent access to sustainable hemp biomass. The raw material can be used in thousands of different products across multiple sectors that are all trying to move towards greener and more sustainable products given the significant environmental, legislation and consumer pressures. From sustainable pulp packaging, to bioplastics to plant based protein and green construction, hemp will become one of the world’s best and most effective solutions in the global drive towards carbon net zero and a circular economy. Furthermore, with each acre of hemp capturing c.10 tons of carbon in a 120 day grow cycle, the Company is putting in place the necessary frameworks to capture and track the unique carbon sequester characteristics of the hemp plant. This will position Change Agronomy to monetise the associated carbon credits on the global voluntary carbon markets where demand for carbon offsets continues to grow exponentially. 

Combining significant IP, superior hemp genetics, large scale cultivation, having already grown in excess of 10,000 acres, a fully built hemp decortication processing facility and significant blue chip customer traction, Change Agronomy is well positioned to scale globally to be a leading player in the global industrial hemp market that is forecast to reach $18.6bn p.a. by 2027. The focus is now to replicate the highly successful industrial hemp hub model developed in Manitoba, Canada, and roll out new industrial hemp hubs across North American, Europe and Africa, initially to provide large scale supply of multiple end hemp plant fractions to cater to the growing demand for high quality consistent biomass supply. Simultaneously the strategy is to vertically integrate into multiple end market hemp based products to further capture the value chain and drive shareholder value. 

“Our family offices are increasingly focused on sustainable investing and financing companies that can be part of the solution to achieve carbon net zero. Change Agronomy sits squarely in those investment cross hairs and as such we were able to deliver our client an oversubscribed financing to allow the Company to accelerate its plans for 2022. We wish Shawn Babcock and the team great success in helping solve one of the world’s most pressing issues with a strong solution that is long overdue”

— Kingsley Wilson, Partner at Chrystal Capital

“We believe hemp products will play a critical role in the circular economy and the global drive towards achieving carbon net zero. Over the past few years we have built and scaled a business that we believe will be a market leader in the large and growing global industrial hemp market as numerous companies look for more sustainable solutions for their products. The ability for hemp to extract up to 10 tonnes of carbon from the atmosphere per acre also means that we will be in a very strong position to be a major supplier of carbon credits to the voluntary carbon markets. We are delighted that Chrystal Capital has been able to not only raise more capital than we had initially been seeking, but also to bring a number of highly strategic family office and corporate investors that both share our sustainable vision for hemp, and will be instrumental in helping us deliver it”

— Shawn Babcock, CEO of Change Agronomy

About Chrystal Capital Sustainability  
 

Chrystal Capital Sustainability focuses on global thematic sustainable and impact investment trends that are being driven by governments, corporations and consumers increasing need to address the move to carbon net zero by 2050. This will be one of the most important and lucrative global secular investment trends over the next decade. Family offices and High Net Worth Individuals are increasingly allocating capital to this developing investment trend. Chrystal Capital is focused on finding, vetting and presenting the best emerging companies that will both help solve the impending crisis and simultaneously deliver significant shareholder returns. Our core areas of expertise in sustainability include: Industrial Hemp, Renewable Energy, Sustainable Transport, Sustainable Food & Agriculture, and Waste & Materials.  

About Change Agronomy   
 

Change Agronomy is a vertically integrated sustainable industrial hemp business that combines world-class genetics with leading agronomic techniques and infrastructure to provide full-service industrial hemp products to multiple global end markets. 

Bringing scale to an important sustainability sector, our vision is committed to a low net-zero future. We aim to become the leading sustainable low-cost producer of hemp products that utilize the whole plant while simultaneously capturing and supplying carbon credits to the growing number of companies globally looking for carbon offset solutions. Harnessing hemp’s potential, we can contribute to solving multiple greenhouse gas emissions, waste, and pollution issues. With a focus on profitable growth, we are driving measurable solutions to climate change. https://www.changeag.com/  

For further information please contact:
Kingsley Wilson
Investment Partner

kingsley.wilson@chrystalcapital.com
https://www.chrystalcapital.com

Deal Announcement: The Every Company (formally Clara Foods)

Chrystal Capital introduces FO and UHNWI co-investors into the $175m Series C financing of The Every Company (formally Clara Foods), alongside Rage Capital

Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has brought co-investors from its family office and UHNWI network into The EVERY Company, a leading precision fermentation platform accelerating a global transition to animal-free protein. The round was co-led by new investor, McWin, and existing investor, Rage Capital. Other new and existing investors joined the round including Temasek, Grosvenor’s Wheatsheaf Group, and TO Ventures.

“Giving family offices access to high growth companies backed by blue chip investors is what Chrystal Capital prides itself on.  Rage Capital is an excellent partner with its vast experience and success in the food tech investing space.  We will be bringing additional deals from them to our network in Q1 and I would encourage any investors interested in the space to reach out.”

— James Innes, Managing Partner, Chrystal

About The Every Company

The EVERY Company, headquartered in South San Francisco, is a market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Originally founded as Clara Foods in 2014, EVERY™ rebranded in 2021 to better capture its vision to bring animal-free proteins to everyone, everywhere.  The company use sugar, yeast, and advanced yeast engineering and fermentation technologies to selectively cultivate yeast for the production of proteins, thereby enabling customers to get healthy, sustainable, and affordable protein items.

Founded by Arturo Elizondo in 2014, Clara’s mission is to create a better, cheaper alternative to animal proteins in both B2C and B2B applications – starting with the egg’s $200B addressable market. Today, the company has developed a comprehensive platform from protein discovery to industry-leading yeast productivity, enabling Every to identify both novel proteins or novel applications of known proteins and synthesize those in mass quantities.

For more information, see www.theeverycompany.com.

About Rage Capital

Rage Capital is a specialist venture capital firm based in New York, investing in cutting edge technology to change the way we eat, live and interact with our planet. Other investments in its portfolio include Blue Nalu, Motif, Ripple, Reef, Future Farm and Splendid Spoon.

For more information, see www.rage-capital.com.


For further information please contact:
James Innes
Managing Partner

james.innes@chrystalcapital.com
https://www.chrystalcapital.com